These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 39337288)
1. The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response. Rivas-Fuentes S; Salgado-Aguayo A; Santos-Mendoza T; Sevilla-Reyes E Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337288 [TBL] [Abstract][Full Text] [Related]
2. Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. Boyoglu-Barnum S; Todd SO; Meng J; Barnum TR; Chirkova T; Haynes LM; Jadhao SJ; Tripp RA; Oomens AG; Moore ML; Anderson LJ J Virol; 2017 May; 91(10):. PubMed ID: 28275196 [TBL] [Abstract][Full Text] [Related]
3. CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. Chirkova T; Lin S; Oomens AGP; Gaston KA; Boyoglu-Barnum S; Meng J; Stobart CC; Cotton CU; Hartert TV; Moore ML; Ziady AG; Anderson LJ J Gen Virol; 2015 Sep; 96(9):2543-2556. PubMed ID: 26297201 [TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561 [TBL] [Abstract][Full Text] [Related]
5. Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies. Bergeron HC; Murray J; Nuñez Castrejon AM; DuBois RM; Tripp RA Viruses; 2021 Feb; 13(2):. PubMed ID: 33672319 [TBL] [Abstract][Full Text] [Related]
6. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis. Harcourt JL; Karron RA; Tripp RA J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257 [TBL] [Abstract][Full Text] [Related]
7. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats. Green G; Johnson SM; Costello H; Brakel K; Harder O; Oomens AG; Peeples ME; Moulton HM; Niewiesk S J Virol; 2021 Jul; 95(16):e0001021. PubMed ID: 34037420 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies. Jones HG; Ritschel T; Pascual G; Brakenhoff JPJ; Keogh E; Furmanova-Hollenstein P; Lanckacker E; Wadia JS; Gilman MSA; Williamson RA; Roymans D; van 't Wout AB; Langedijk JP; McLellan JS PLoS Pathog; 2018 Mar; 14(3):e1006935. PubMed ID: 29509814 [TBL] [Abstract][Full Text] [Related]
9. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein. Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains. Choi Y; Mason CS; Jones LP; Crabtree J; Jorquera PA; Tripp RA Viral Immunol; 2012 Jun; 25(3):193-203. PubMed ID: 22551066 [TBL] [Abstract][Full Text] [Related]
11. Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. Zhang W; Choi Y; Haynes LM; Harcourt JL; Anderson LJ; Jones LP; Tripp RA J Virol; 2010 Jan; 84(2):1148-57. PubMed ID: 19864390 [TBL] [Abstract][Full Text] [Related]
12. The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis. Anderson J; Do LAH; van Kasteren PB; Licciardi PV EBioMedicine; 2024 Sep; 107():105318. PubMed ID: 39217853 [TBL] [Abstract][Full Text] [Related]
13. Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection. Johnson CH; Miao C; Blanchard EG; Caidi H; Radu GU; Harcourt JL; Haynes LM Comp Med; 2012 Feb; 62(1):14-20. PubMed ID: 22330646 [TBL] [Abstract][Full Text] [Related]
14. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504 [TBL] [Abstract][Full Text] [Related]
15. CX3CR1 as a respiratory syncytial virus receptor in pediatric human lung. Anderson CS; Chu CY; Wang Q; Mereness JA; Ren Y; Donlon K; Bhattacharya S; Misra RS; Walsh EE; Pryhuber GS; Mariani TJ Pediatr Res; 2020 Apr; 87(5):862-867. PubMed ID: 31726465 [TBL] [Abstract][Full Text] [Related]
16. Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. Johnson SM; McNally BA; Ioannidis I; Flano E; Teng MN; Oomens AG; Walsh EE; Peeples ME PLoS Pathog; 2015 Dec; 11(12):e1005318. PubMed ID: 26658574 [TBL] [Abstract][Full Text] [Related]
17. m Picavet LW; van Vroonhoven ECN; Scholman RC; Smits YTH; Banerjee R; Besteman SB; Viveen MC; van der Vlist MM; Tanenbaum ME; Lebbink RJ; Vastert SJ; van Loosdregt J Viruses; 2024 May; 16(5):. PubMed ID: 38793659 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats. Martinez ME; Capella Gonzalez C; Huey D; Peeples ME; McCarty D; Niewiesk S PLoS One; 2021; 16(2):e0246770. PubMed ID: 33600439 [TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response. Das S; Raundhal M; Chen J; Oriss TB; Huff R; Williams JV; Ray A; Ray P JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878128 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]